BOSTON – October 29, 2026 -- VUE Health, an independent healthcare advertising agency serving emerging biopharma companies, has been named Healthcare Advertising Agency of the Year 2026 by Healthcare Business Review, which also made the agency its cover story. Founder and CEO Kathryn Wilson was separately named one of the Top 10 Inspiring Women Entrepreneurs to Watch in 2026 in an MSN feature.
Castleman disease launch delivers 99.8% message recall and 33% sales growth
VUE Health cites a rare disease launch as its proof point. The Castleman disease therapy faced limited awareness and widespread misdiagnosis, and the agency prepared its launch in about 90 days. An interactive "castle" experience at the American Society of Hematology (ASH) annual meeting helped drive 99.8% recall of five key messages among participants. The product recorded 33% month-over-month, year-over-year sales growth.
Sync Sprint method can compress go-to-market to 90 days
The agency's Sync Sprint methodology can bring a product or program to market in as little as 90 days when circumstances demand it. It starts with scientific immersion, market understanding and strategic alignment before execution accelerates.
A multidisciplinary medical team of PhDs and PharmDs works alongside strategy and creative teams. VUE Health also runs internal platforms for workflow and resource management. A proprietary capability assembles custom teams from employees and a network of vetted experts, and AI tools speed scientific dialogue with key opinion leaders.
Senior-led staffing model targets emerging biopharma launches
VUE Health says senior strategists, scientists, medical professionals and creative leaders stay involved throughout commercialization, rather than handing accounts to junior teams. Clients call it the "non-agency agency." The agency focuses on oncology, rare disease, central nervous system conditions and novel delivery technologies, categories where awareness, diagnosis and clinical education are often the critical barriers.
Wilson and Chief Medical Officer and Partner Vikram Kanda, PhD, a scientist trained in molecular cardiology, work with clients as strategic peers. The agency says this suits emerging biopharma companies whose first commercial hires are often building a launch with limited internal support.
Wilson says growth is not the goal
Wilson founded the agency after rising through senior agency roles, where she spent less time on client commercialization challenges and more on P&Ls and operations. "We are not trying to become the biggest agency," she said, adding that the focus is on being the right partner for companies developing therapies where the team's experience can make a difference.
The agency continues to expand across media, public relations, technology platforms and specialized scientific expertise. Named leaders include Meaghan Taft, SVP Client Service; Ohad Cohen, Executive Creative Director; and Dan Hurley, SVP Innovation, who oversees the omnichannel media team.